Atypical chronic myeloid leukemia, BCR/ABL-negative, not having achieved remission digital illustration

Atypical chronic myeloid leukemia, BCR/ABL-negative, not having achieved remission Save


ICD-10 code: C92.20

Disease category: C92.2: Atypical chronic myeloid leukemia, BCR/ABL-negative

Understanding Atypical Chronic Myeloid Leukemia, BCR/ABL-Negative, Not Having Achieved Remission

Atypical Chronic Myeloid Leukemia (aCML) is a rare form of blood cancer that affects the bone marrow and blood cells. It is a type of myeloproliferative neoplasm, which means there is an overproduction of blood cells in the bone marrow. However, unlike other forms of chronic myeloid leukemia (CML), aCML is BCR/ABL-negative, meaning it does not have the genetic mutation that is commonly found in CML. Additionally, this type of cancer is often resistant to treatment and can be difficult to achieve remission.

Individuals with aCML may experience a range of symptoms, including fatigue, weakness, fever, weight loss, and night sweats. They may also have an enlarged spleen, which can cause pain and discomfort in the abdomen. Due to the rarity of this disease, it is often misdiagnosed or diagnosed at a late stage.

  1. Causes: The exact cause of aCML is unknown, but it is believed to be related to genetic mutations in the bone marrow cells that produce blood cells.
  2. Diagnosis: A diagnosis of aCML is usually made through a bone marrow biopsy and blood tests. The biopsy can show an overproduction of abnormal blood cells, while the blood tests can confirm the absence of the BCR/ABL genetic mutation.
  3. Treatment: There is no standard treatment for aCML, and the approach may vary depending on the individual's age, overall health, and other factors. Treatment options may include chemotherapy, targeted therapy, and stem cell transplant.
  4. Prognosis: The prognosis for individuals with aCML is generally poor, with a median survival rate of 12-24 months. However, some individuals may respond to treatment and achieve remission.

If you or a loved one has been diagnosed with aCML, it is important to seek medical care from a team of experts who are experienced in treating this rare form of cancer. While there is no cure for aCML, early detection and treatment can help manage symptoms and improve quality of life.

Treatment of Atypical chronic myeloid leukemia, BCR/ABL-negative, not having achieved remission:

Treatment Options for Atypical Chronic Myeloid Leukemia, BCR/ABL-Negative, Not Having Achieved Remission
Atypical chronic myeloid leukemia (aCML) is a rare type of leukemia that affects the white blood cells. It is characterized by the presence of abnormal cells known as myelocytes in the bone marrow and blood. While aCML is similar to chronic myeloid leukemia (CML), it is BCR/ABL-neg...

To see full information about treatment please Sign up or Log in